Categories: Healthcare

PowerTalk: A Profitable Diagnosis on Health-care Investing

Investing can be fun and profitable at times, but it also can be tricky. There are hundreds, if not thousands, of companies to choose from in dozens and dozens of industries. Some are new and thriving like wireless, broadband and social media. That’s great for companies like Qualcomm (QCOM), Entropic (ENTR) and Facebook (FB), as well as their shareholders. Others like newspapers such as the New York Times (NYT), book publishers and retail book stores like Barnes & Noble (BKS) are feeling the pain as their industries adapt to what I call the Always On, Always Connected society.

The economy and industry fundamentals are not the only thing to watch and listen to with your investing eyes and ears. One other aspect is the regulatory environment and more specifically new regulations. As we know, business has been saddled with a number of them over the last few years, but none have the ability to impact the cost structure of a business like the Affordable Care Act, which is more commonly known as Obamacare.

We’ve done a few PowerTalks already that have looked at the implications of Obamacare and other regulations. This week, we’re talking about how you can profit from these regulations.

Joining me this week on PowerTalk are George Abraham and Sumesh Sood of Veda Healthcare Partners. Veda is a hedge fund that has been in operation for more than two and a half years and invests in healthcare. From biotech and pharmaceuticals to managed care and generic drugs, these guys are looking at all of it with an eye toward delivering profits for their investors.

Health-care investing can be a tricky thing, but when we look around and see just the shifting demographics — living longer, a heavier population, nutritional concerns and more — it’s apparent that there are a number of pain points. For me, pain points mean opportunity for the prepared investor. Let’s listen to what George and Sumesh see as remedies for not only these issues but also for your wallet.

Listen to my behind-the-scenes PowerTalk conversation now, so you are even more in the know:

Special introductory offer: Right now you can try Chris Versace’s PowerTrend Profits risk-free for only $99.95! Find out how, here.

Access prior PowerTalk interviews here:

Rolling in the Dough, CEO of Panera Bread Finds Profitable Recipe

Navigating the Airways with BlackJet CEO Dean Rotchin

Abe’s Market — More than the Intersection of Amazon.com and Whole Foods

What You Need to Know as the Fed Gets Ready to Taper its Stimulus: Advice from Experts Douglas Holtz-Eakin and Diana Furchtgott-Roth

Sizing up Cyber Security with Sourcefire (FIRE) CTO and Founder Martin Roesch

Chris Versace

Chris Versace is a veteran equity analyst and contributing editor to Eagle Daily Investor. His research has been covered in The Wall Street Journal, Forbes, Investor's Business Daily, and numerous other publications.

Recent Posts

Slow GO: Is a Bear Market and Hard Landing Coming?

“Congratulations on your work. It has been a long slog to get the national accounts…

3 days ago

Broken Wing Butterfly and Butterfly Spread – Option Trading Strategies

The broken wing butterfly and the butterfly spread are two different types of option trading…

3 days ago

Bear Call Spread and Bear Put Spread – Option Trading Strategies

The bear call spread and the bear put spread are option strategies used when an…

3 days ago

When Mises Met MMA

It’s not often that you hear the brilliant Austrian school economist Ludwig von Mises referenced…

4 days ago

ETF Talk: Tapping into the Power of Language with This Communications ETF

While Charles Dickens’s famous statement, “It was the best of times, it was the worst…

4 days ago

Five Advantages to Day-Trading with a 90% Win Rate

Five advantages to day-trading with a 90% win rate offer a tempting opportunity. The five…

4 days ago